SPR Highlights EP#33 [Geto]: Rastreamento do Câncer de Pulmão

SPR Highlights

Nesse episódio do Geto Highlights, que faz parte da série de entrevistas gravadas durante a JPR 2019, em maio de 2019, o Dr. Marcos Duarte conversa sobre o rastreamento do câncer de pulmão com o Dr. Ricardo Sales. Abaixo, seguem os artigos de referência dessa entrevista: Do Current Lung Cancer Screening Guidelines Apply for Populations With High Prevalence of Granulomatous Disease? Results From the First Brazilian Lung Cancer Screening Trial (BRELT1). https://www.ncbi.nlm.nih.gov/pubmed/26409711 NELSON Trial: ‘’Call to Action’’ for Lung Cancer CT Screening of High-Risk Individuals: https://www.ascopost.com/issues/october-25-2018/nelson-trial/ Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening https://www.nejm.org/doi/full/10.1056/NEJMoa1102873 Low dose CT lung cancer screening is proven cost-effective https://lungcanceralliance.org/for-professionals/cost-effectiveness-of-lung-cancer-screening/ Manchester’s Lung Health Check Pilot https://mft.nhs.uk/app/uploads/sites/12/2019/02/lung-health-check-manchester-report_tcm9-309848.pdf Telehealth https://www.nejm.org/doi/full/10.1056/NEJMsr1503323 Propulmão http://www.propulmao.com.br/ Slow Medicine https://www.slowmedicine.com.br/ Fast Tracking http://erassociety.org/ Confira a agenda de reuniões do Geto em https://spr.org.br/grupos-de-estudos/geto-grupo-de-estudos-do-torax/ e participe online (https://spr.org.br/cursos-via-web/).